← All agents | ← Research tracker
Ivermectin
Also known as: Ivermectin
PubChem entry
Evidence Summary
Evidence Level: Moderate
Mechanism: Enrollment: Actual, Sponsor Type: Other, Unknown / General
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 1 associated trial(s) and 1 study reference(s) in current data. Review primary sources and consult specialists before use.
Related Conditions
Long COVID (no page yet) · Lyme (no page yet)
Clinical Trials
1 trial(s) registered
NCT04510194: COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) PHASE3 COMPLETED
Key Studies / References